APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Artificial Tears

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Artificial Tears Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchOTC Artificial Tears Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Artificial Tears Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal OTC Artificial Tears Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Artificial Tears Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Artificial Tears Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global OTC Artificial Tears market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for OTC Artificial Tears is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Artificial Tears is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Artificial Tears is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Artificial Tears is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Artificial Tears include Akorn, Inc., Alcon, Bausch and Lamb, OcuSoft, Similasan Corporation, Sun Pharmaceutical Industries Limited, Ursapharm Arzneimittel GmbH, AbbVie, Inc. and Santen Pharmaceutical Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global OTC Artificial Tears market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Artificial Tears and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Artificial Tears sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the OTC Artificial Tears market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Artificial Tears Segment by Company

Akorn, Inc.

Alcon

Bausch and Lamb

OcuSoft

Similasan Corporation

Sun Pharmaceutical Industries Limited

Ursapharm Arzneimittel GmbH

AbbVie, Inc.

Santen Pharmaceutical Co. Ltd

Johnson and Johnson

OTC Artificial Tears Segment by Type

Preservative Based

Non-preservative Based

OTC Artificial Tears Segment by Application

Hospital Pharmacies

Drug Stores

Online

OTC Artificial Tears Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Artificial Tears market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Artificial Tears and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Artificial Tears.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the OTC Artificial Tears market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OTC Artificial Tears manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of OTC Artificial Tears in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of OTC Artificial Tears in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. OTC Artificial Tears Industry Trends Table 2. OTC Artificial Tears Industry Drivers Table 3. OTC Artificial Tears Industry Opportunities and Challenges Table 4. OTC Artificial Tears Industry Restraints Table 5. Global OTC Artificial Tears Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global OTC Artificial Tears Revenue Market Share by Manufacturers (2021-2026) Table 7. Global OTC Artificial Tears Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global OTC Artificial Tears Sales Market Share by Manufacturers Table 9. Global OTC Artificial Tears Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global OTC Artificial Tears Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global OTC Artificial Tears Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global OTC Artificial Tears Manufacturers, Product Type & Application Table 13. Global OTC Artificial Tears Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global OTC Artificial Tears by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Preservative Based Table 17. Major Manufacturers of Non-preservative Based Table 18. Global OTC Artificial Tears Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global OTC Artificial Tears Sales by Type (2021-2026) & (K Units) Table 20. Global OTC Artificial Tears Sales by Type (2027-2032) & (K Units) Table 21. Global OTC Artificial Tears Sales Market Share by Type (2021-2026) Table 22. Global OTC Artificial Tears Sales Market Share by Type (2027-2032) Table 23. Global OTC Artificial Tears Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global OTC Artificial Tears Revenue by Type (2021-2026) & (K Units) Table 25. Global OTC Artificial Tears Revenue by Type (2027-2032) & (K Units) Table 26. Global OTC Artificial Tears Revenue Market Share by Type (2021-2026) Table 27. Global OTC Artificial Tears Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Pharmacies Table 29. Major Manufacturers of Drug Stores Table 30. Major Manufacturers of Online Table 31. Global OTC Artificial Tears Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global OTC Artificial Tears Sales by Application (2021-2026) & (K Units) Table 33. Global OTC Artificial Tears Sales by Application (2027-2032) & (K Units) Table 34. Global OTC Artificial Tears Sales Market Share by Application (2021-2026) Table 35. Global OTC Artificial Tears Sales Market Share by Application (2027-2032) Table 36. Global OTC Artificial Tears Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global OTC Artificial Tears Revenue by Application (2021-2026) & (K Units) Table 38. Global OTC Artificial Tears Revenue by Application (2027-2032) & (K Units) Table 39. Global OTC Artificial Tears Revenue Market Share by Application (2021-2026) Table 40. Global OTC Artificial Tears Revenue Market Share by Application (2027-2032) Table 41. Global OTC Artificial Tears Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global OTC Artificial Tears Sales by Region (2021-2026) & (K Units) Table 43. Global OTC Artificial Tears Sales Market Share by Region (2021-2026) Table 44. Global OTC Artificial Tears Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global OTC Artificial Tears Sales Forecasted Market Share by Region (2027-2032) Table 46. North America OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America OTC Artificial Tears Sales by Country (2021-2026) & (K Units) Table 48. North America OTC Artificial Tears Sales by Country (2027-2032) & (K Units) Table 49. Europe OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe OTC Artificial Tears Sales by Country (2021-2026) & (K Units) Table 51. Europe OTC Artificial Tears Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific OTC Artificial Tears Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific OTC Artificial Tears Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa OTC Artificial Tears Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa OTC Artificial Tears Sales by Country (2027-2032) & (K Units) Table 58. Global OTC Artificial Tears Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global OTC Artificial Tears Revenue by Region (2021-2026) & (US$ Million) Table 60. Global OTC Artificial Tears Revenue by Region (2027-2032) & (US$ Million) Table 61. Global OTC Artificial Tears Revenue Market Share by Region (2021-2026) Table 62. Global OTC Artificial Tears Revenue Market Share by Region (2027-2032) Table 63. Akorn, Inc. Company Information Table 64. Akorn, Inc. Business Overview Table 65. Akorn, Inc. OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Akorn, Inc. OTC Artificial Tears Product Portfolio Table 67. Akorn, Inc. Recent Development Table 68. Alcon Company Information Table 69. Alcon Business Overview Table 70. Alcon OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alcon OTC Artificial Tears Product Portfolio Table 72. Alcon Recent Development Table 73. Bausch and Lamb Company Information Table 74. Bausch and Lamb Business Overview Table 75. Bausch and Lamb OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bausch and Lamb OTC Artificial Tears Product Portfolio Table 77. Bausch and Lamb Recent Development Table 78. OcuSoft Company Information Table 79. OcuSoft Business Overview Table 80. OcuSoft OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. OcuSoft OTC Artificial Tears Product Portfolio Table 82. OcuSoft Recent Development Table 83. Similasan Corporation Company Information Table 84. Similasan Corporation Business Overview Table 85. Similasan Corporation OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Similasan Corporation OTC Artificial Tears Product Portfolio Table 87. Similasan Corporation Recent Development Table 88. Sun Pharmaceutical Industries Limited Company Information Table 89. Sun Pharmaceutical Industries Limited Business Overview Table 90. Sun Pharmaceutical Industries Limited OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Industries Limited OTC Artificial Tears Product Portfolio Table 92. Sun Pharmaceutical Industries Limited Recent Development Table 93. Ursapharm Arzneimittel GmbH Company Information Table 94. Ursapharm Arzneimittel GmbH Business Overview Table 95. Ursapharm Arzneimittel GmbH OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Ursapharm Arzneimittel GmbH OTC Artificial Tears Product Portfolio Table 97. Ursapharm Arzneimittel GmbH Recent Development Table 98. AbbVie, Inc. Company Information Table 99. AbbVie, Inc. Business Overview Table 100. AbbVie, Inc. OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. AbbVie, Inc. OTC Artificial Tears Product Portfolio Table 102. AbbVie, Inc. Recent Development Table 103. Santen Pharmaceutical Co. Ltd Company Information Table 104. Santen Pharmaceutical Co. Ltd Business Overview Table 105. Santen Pharmaceutical Co. Ltd OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Santen Pharmaceutical Co. Ltd OTC Artificial Tears Product Portfolio Table 107. Santen Pharmaceutical Co. Ltd Recent Development Table 108. Johnson and Johnson Company Information Table 109. Johnson and Johnson Business Overview Table 110. Johnson and Johnson OTC Artificial Tears Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Johnson and Johnson OTC Artificial Tears Product Portfolio Table 112. Johnson and Johnson Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. OTC Artificial Tears Distributors List Table 116. OTC Artificial Tears Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. OTC Artificial Tears Product Image Figure 2. Global OTC Artificial Tears Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Artificial Tears Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Artificial Tears Sales (2021-2032) & (K Units) Figure 5. Global OTC Artificial Tears Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 OTC Artificial Tears Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Preservative Based Image Figure 9. Non-preservative Based Image Figure 10. Global OTC Artificial Tears Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global OTC Artificial Tears Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global OTC Artificial Tears Sales Market Share by Type (2021-2032) Figure 13. Global OTC Artificial Tears Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global OTC Artificial Tears Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global OTC Artificial Tears Revenue Market Share by Type (2021-2032) Figure 16. Hospital Pharmacies Image Figure 17. Drug Stores Image Figure 18. Online Image Figure 19. Global OTC Artificial Tears Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global OTC Artificial Tears Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global OTC Artificial Tears Sales Market Share by Application (2021-2032) Figure 22. Global OTC Artificial Tears Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global OTC Artificial Tears Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global OTC Artificial Tears Revenue Market Share by Application (2021-2032) Figure 25. North America OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America OTC Artificial Tears Sales Market Share by Country (2021-2032) Figure 27. U.S. OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe OTC Artificial Tears Sales Market Share by Country (2021-2032) Figure 32. Germany OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific OTC Artificial Tears Sales Market Share by Country (2021-2032) Figure 39. China OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa OTC Artificial Tears Sales Market Share by Country (2021-2032) Figure 47. Brazil OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile OTC Artificial Tears Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global OTC Artificial Tears Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global OTC Artificial Tears Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America OTC Artificial Tears Revenue (2021-2032) & (US$ Million) Figure 58. North America OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe OTC Artificial Tears Revenue (2021-2032) & (US$ Million) Figure 60. Europe OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific OTC Artificial Tears Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa OTC Artificial Tears Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. OTC Artificial Tears Value Chain Figure 66. Manufacturing Cost Structure Figure 67. OTC Artificial Tears Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Preservative Based
  • Non-preservative Based
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online
Companies covered
  • Akorn, Inc.
  • Alcon
  • Bausch and Lamb
  • OcuSoft
  • Similasan Corporation
  • Sun Pharmaceutical Industries Limited
  • Ursapharm Arzneimittel GmbH
  • AbbVie, Inc.
  • Santen Pharmaceutical Co. Ltd
  • Johnson and Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Artificial Tears Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Artificial Tears Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global OTC Artificial Tears Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global OTC Artificial Tears Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global OTC Artificial Tears Market Dynamics
  1. 2.1 OTC Artificial Tears Industry Trends
  2. 2.2 OTC Artificial Tears Industry Drivers
  3. 2.3 OTC Artificial Tears Industry Opportunities and Challenges
  4. 2.4 OTC Artificial Tears Industry Restraints
3 OTC Artificial Tears Market by Manufacturers
  1. 3.1 Global OTC Artificial Tears Revenue by Manufacturers (2021-2026)
  2. 3.2 Global OTC Artificial Tears Sales by Manufacturers (2021-2026)
  3. 3.3 Global OTC Artificial Tears Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global OTC Artificial Tears Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OTC Artificial Tears Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global OTC Artificial Tears Manufacturers, Product Type & Application
  7. 3.7 Global OTC Artificial Tears Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OTC Artificial Tears Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OTC Artificial Tears Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OTC Artificial Tears Tier 1, Tier 2, and Tier 3
4 OTC Artificial Tears Market by Type
  1. 4.1 OTC Artificial Tears Type Introduction
  2. 4.1.1 Preservative Based
  3. 4.1.2 Non-preservative Based
  4. 4.2 Global OTC Artificial Tears Sales by Type
  5. 4.2.1 Global OTC Artificial Tears Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global OTC Artificial Tears Sales by Type (2021-2032)
  7. 4.2.3 Global OTC Artificial Tears Sales Market Share by Type (2021-2032)
  8. 4.3 Global OTC Artificial Tears Revenue by Type
  9. 4.3.1 Global OTC Artificial Tears Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global OTC Artificial Tears Revenue by Type (2021-2032)
  11. 4.3.3 Global OTC Artificial Tears Revenue Market Share by Type (2021-2032)
5 OTC Artificial Tears Market by Application
  1. 5.1 OTC Artificial Tears Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online
  5. 5.2 Global OTC Artificial Tears Sales by Application
  6. 5.2.1 Global OTC Artificial Tears Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Artificial Tears Sales by Application (2021-2032)
  8. 5.2.3 Global OTC Artificial Tears Sales Market Share by Application (2021-2032)
  9. 5.3 Global OTC Artificial Tears Revenue by Application
  10. 5.3.1 Global OTC Artificial Tears Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global OTC Artificial Tears Revenue by Application (2021-2032)
  12. 5.3.3 Global OTC Artificial Tears Revenue Market Share by Application (2021-2032)
6 Global OTC Artificial Tears Sales by Region
  1. 6.1 Global OTC Artificial Tears Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Artificial Tears Sales by Region (2021-2032)
  3. 6.2.1 Global OTC Artificial Tears Sales by Region (2021-2026)
  4. 6.2.2 Global OTC Artificial Tears Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America OTC Artificial Tears Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe OTC Artificial Tears Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific OTC Artificial Tears Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa OTC Artificial Tears Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa OTC Artificial Tears Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global OTC Artificial Tears Revenue by Region
  1. 7.1 Global OTC Artificial Tears Revenue by Region
  2. 7.1.1 Global OTC Artificial Tears Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global OTC Artificial Tears Revenue by Region (2021-2026)
  4. 7.1.3 Global OTC Artificial Tears Revenue by Region (2027-2032)
  5. 7.1.4 Global OTC Artificial Tears Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America OTC Artificial Tears Revenue (2021-2032)
  8. 7.2.2 North America OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe OTC Artificial Tears Revenue (2021-2032)
  11. 7.3.2 Europe OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific OTC Artificial Tears Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa OTC Artificial Tears Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa OTC Artificial Tears Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn, Inc.
  2. 8.1.1 Akorn, Inc. Company Information
  3. 8.1.2 Akorn, Inc. Business Overview
  4. 8.1.3 Akorn, Inc. OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akorn, Inc. OTC Artificial Tears Product Portfolio
  6. 8.1.5 Akorn, Inc. Recent Developments
  7. 8.2 Alcon
  8. 8.2.1 Alcon Company Information
  9. 8.2.2 Alcon Business Overview
  10. 8.2.3 Alcon OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alcon OTC Artificial Tears Product Portfolio
  12. 8.2.5 Alcon Recent Developments
  13. 8.3 Bausch and Lamb
  14. 8.3.1 Bausch and Lamb Company Information
  15. 8.3.2 Bausch and Lamb Business Overview
  16. 8.3.3 Bausch and Lamb OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bausch and Lamb OTC Artificial Tears Product Portfolio
  18. 8.3.5 Bausch and Lamb Recent Developments
  19. 8.4 OcuSoft
  20. 8.4.1 OcuSoft Company Information
  21. 8.4.2 OcuSoft Business Overview
  22. 8.4.3 OcuSoft OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 OcuSoft OTC Artificial Tears Product Portfolio
  24. 8.4.5 OcuSoft Recent Developments
  25. 8.5 Similasan Corporation
  26. 8.5.1 Similasan Corporation Company Information
  27. 8.5.2 Similasan Corporation Business Overview
  28. 8.5.3 Similasan Corporation OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Similasan Corporation OTC Artificial Tears Product Portfolio
  30. 8.5.5 Similasan Corporation Recent Developments
  31. 8.6 Sun Pharmaceutical Industries Limited
  32. 8.6.1 Sun Pharmaceutical Industries Limited Company Information
  33. 8.6.2 Sun Pharmaceutical Industries Limited Business Overview
  34. 8.6.3 Sun Pharmaceutical Industries Limited OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharmaceutical Industries Limited OTC Artificial Tears Product Portfolio
  36. 8.6.5 Sun Pharmaceutical Industries Limited Recent Developments
  37. 8.7 Ursapharm Arzneimittel GmbH
  38. 8.7.1 Ursapharm Arzneimittel GmbH Company Information
  39. 8.7.2 Ursapharm Arzneimittel GmbH Business Overview
  40. 8.7.3 Ursapharm Arzneimittel GmbH OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ursapharm Arzneimittel GmbH OTC Artificial Tears Product Portfolio
  42. 8.7.5 Ursapharm Arzneimittel GmbH Recent Developments
  43. 8.8 AbbVie, Inc.
  44. 8.8.1 AbbVie, Inc. Company Information
  45. 8.8.2 AbbVie, Inc. Business Overview
  46. 8.8.3 AbbVie, Inc. OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie, Inc. OTC Artificial Tears Product Portfolio
  48. 8.8.5 AbbVie, Inc. Recent Developments
  49. 8.9 Santen Pharmaceutical Co. Ltd
  50. 8.9.1 Santen Pharmaceutical Co. Ltd Company Information
  51. 8.9.2 Santen Pharmaceutical Co. Ltd Business Overview
  52. 8.9.3 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Product Portfolio
  54. 8.9.5 Santen Pharmaceutical Co. Ltd Recent Developments
  55. 8.10 Johnson and Johnson
  56. 8.10.1 Johnson and Johnson Company Information
  57. 8.10.2 Johnson and Johnson Business Overview
  58. 8.10.3 Johnson and Johnson OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Johnson and Johnson OTC Artificial Tears Product Portfolio
  60. 8.10.5 Johnson and Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 OTC Artificial Tears Value Chain Analysis
  2. 9.1.1 OTC Artificial Tears Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 OTC Artificial Tears Production Mode & Process
  6. 9.2 OTC Artificial Tears Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 OTC Artificial Tears Distributors
  9. 9.2.3 OTC Artificial Tears Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst